Telangana excelling in pharma sector: KT Rama Rao

Pharma hub Hyderabad’s life sciences sector currently has a revenue base of $50 billion, which will be doubled by 2030. Projects such as Hyderabad Pharma City and Genome Valley 2.0 and Medical Devices Park are going to attract investments in future. Medtronics has recently announced a major investment in city while Sahajanand Medical Technologies is going to set up Asia’s largest stent manufacturing



facility.

Speaking at an interactive meeting on ‘Transforming Hyderabad into a global city’ here on Thursday, Telangana Industries Minister K T Rama Rao said, “Hyderabad today accounts for 35 per cent of the country’s bulk drugs production. We are also a major vaccines supplier. We will double revenues as well as generate jobs.”